Amedas, UAB - financials and debts

Company age: 17 y. 1 mo.

Update

Amedas - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 78,377 153,452 93,220 106,144 84,273 117,005 103,813 252,409
Profit before tax - - - - -1,672 -784 543 833
Net profit 9,290 12,274 -5,287 -9,141 -1,672 -784 480 759
Equity 93,626 106,405 100,686 93,696 92,534 91,750 92,229 92,988
Liabilities 31,320 21,063 10,667 15,752 15,625 15,074 27,356 67,417
Non-current assets 2,947 3,327 4,185 4,731 4,453 3,984 7,020 7,075
Current assets 121,793 123,943 107,149 104,600 103,385 102,576 112,318 153,115
Total assets 124,740 127,270 111,334 109,331 107,838 106,560 119,338 160,190
Taxes paid
STI taxes - - - - - 16,558 12,139 34,268
Financial indicators
Revenue change y/y -27.1% +95.8% -39.3% +13.9% -20.6% +38.8% -11.3% +143.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 7.4% 9.6% -4.7% -8.4% -1.6% -0.7% 0.4% 0.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 9.9% 11.5% -5.3% -9.8% -1.8% -0.9% 0.5% 0.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 11.9% 8.0% -5.7% -8.6% -2.0% -0.7% 0.5% 0.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - -2.0% -0.7% 0.5% 0.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.3 0.2 0.1 0.2 0.2 0.2 0.3 0.7
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 39,189 76,726 46,610 53,072 42,137 58,503 51,907 126,205

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Amedas - Social security debts

From To Debt, €
2026-02-18 2026-02-22 254.54
2025-10-16 2025-10-19 212.47
2023-10-17 2023-10-19 98.09
2023-06-16 2023-06-18 97.92
2023-04-18 2023-04-18 92.12
2022-07-18 2022-07-19 190.63
2021-10-18 2021-10-19 20.70

Amedas - VMI tax arrears

From To Overdue, €
2026-08-12 2026-08-17 0.54
2026-08-02 2026-08-07 321.46
2026-03-17 2026-03-19 1.1
2026-02-28 2026-03-16 1.96
2025-10-30 2025-11-15 0.96
2025-10-02 2025-10-24 0.96
2025-09-30 2025-10-01 0.79
2025-09-28 2025-09-29 0.23
2025-08-28 2025-09-17 0.23

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Amedas, UAB (code 302428401) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €252.4K, up 143.1% year on year and 115.7% over two years, indicating a strong expansion in sales. Net profit for 2025 was €759, compared with €480 in 2024 and a loss of €784 in 2023, so profitability recovered and remained positive, although the net margin stayed modest at 0.3%. The three-year trend shows revenue moving from €117.0K in 2023 to €103.8K in 2024 and then rising sharply in 2025. Total assets increased to €160.2K in 2025 from €119.3K a year earlier, while equity was €93.0K and liabilities €67.4K. The equity ratio stood at 58.0%, debt-to-equity at 0.73, and asset turnover at 1.58x. Return on equity was 0.8% and return on assets 0.5%, reflecting low but positive profitability. Revenue per employee was €126.2K, with profit per employee of €380.